#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Behcet's syndrome Cutaneous lupus erythematosus Peripheral T-cell lymphoma unspecified Primitive neuroectodermal tumour Myeloid leukaemia Toxic epidermal necrolysis Colitis ulcerative Intracranial germ cell tumour Mucous membrane pemphigoid Vulval cancer recurrent High-grade B-cell lymphoma Non-Hodgkin's lymphoma refractory Glomerulonephritis membranoproliferative Soft tissue sarcoma Wolfram syndrome More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Diagnostics Immunodeficiency congenital – Trials in Disease Rosai-Dorfman syndrome – Life with Disease Mantle cell lymphoma stage II Medulloblastoma – Diagnostics Ewing’s sarcoma Crigler-Najjar syndrome – Diagnostics Synovial sarcoma – Diagnostics Mitochondrial myopathy – Basic Information Gastrointestinal stromal tumour – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-LEUCINE Tetracaine Hydrochloride Tak-280 Mk-4830 Ion440 Apremilast Rifapentine Gadobutrol Grwd5769 Ranibizumab Sapablursen Cobolimab Ibutamoren Mesilate Metoprolol Citalopram Hydrochloride Calcium Carbonate Zagociguat Co-Trimoxazole Paclitaxel Alendronate Sodium Monohydrate More therapies…

    Learn about Your Condition

    Drug use disorder Electrocorticogram Exposure via breast milk Chronic lymphocytic leukaemia Heparin resistance Extra-osseous Ewing's sarcoma Vulvovaginal discomfort Medication overuse headache Alport's syndrome Crigler-Najjar syndrome Pancreatitis relapsing Immune-mediated renal disorder Deep vein thrombosis Postpartum haemorrhage Catatonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lung neoplasm malignant

  • Study on the Effectiveness of Atezolizumab, Carboplatin, and Nab-Paclitaxel in Patients with Resectable Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Paclitaxel Albumin-Bound
    Germany

  • Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Domvanalimab
    • Durvalumab
    • Infliximab
    Belgium France Germany Greece Hungary Italy +4

  • Study on Atezolizumab for Patients with Lung and Liver Cancer Using Digital Health Solutions

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Hepatic cancer
    Investigated Drugs:
    • Atezolizumab
    Austria Germany Spain

  • Study on Chemotherapy with Paclitaxel, Cisplatin, and Carboplatin for Patients with Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Non-small cell lung cancer stage I
    • Non-small cell lung cancer stage II
    Investigated Drugs:
    • Vinorelbine Tartrate
    • Carboplatin
    • Cisplatin
    France Germany

  • Study of Rilvegostomig (AZD2936) for Adults with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Rilvegostomig
    Belgium Denmark France The Netherlands Spain

  • Study Comparing Pralsetinib and Standard Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pralsetinib
    • Carboplatin
    • Cisplatin
    Belgium France Germany Ireland Italy The Netherlands +4
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!